The Insertion of an Evolutionary Lost Four-Amino-Acid Cytoplasmic Tail Peptide into a Syncytin-1 Vaccine Increases T- and B-Cell Responses in Mice
Viruses · 03.08.2023 · 15 (8) · 1686
DOI: 10.3390/v15081686 ↗Kurz gefasst
Fachartikel in der Zeitschrift Viruses, online erschienen am 03.08.2023. Verfasst von Isabella Skandorff und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Immunology and Microbiology, University of Copenhagen, Blegdamsvej 3B, 2200 Copenhagen, Denmark. Hauptthemen laut MEDLINE: Pregnancy Proteins, Cancer Vaccines, Endogenous Retroviruses. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Eurostars-2 programme.
Abstract (Originalsprache)
Human endogenous retrovirus type W (HERV-W) is expressed in various cancers. We previously developed an adenovirus-vectored cancer vaccine targeting HERV-W by encoding an assembled HERV-W group-specific antigen sequence and the HERV-W envelope sequence Syncytin-1. Syncytin-1 is constitutively fusogenic and forms large multinucleated cell fusions when overexpressed. Consequently, immunising humans with a vaccine encoding Syncytin-1 can lead to the formation of extensive syncytia, which is undesirable and poses a potential safety issue. Here, we show experiments in cell lines that restoring an evolutionary lost cleavage site of the fusion inhibitory R-peptide of Syncytin-1 inhibit cell fusion. Interestingly, this modification of the HERV-W vaccine’s fusogenicity increased the expression of the vaccine antigens in vitro. It also enhanced Syncytin-1-specific antibody responses and CD8+-mediated T-cell responses compared to the wildtype vaccine in vaccinated mice, with a notable enhancement in responses to subdominant T-cell epitopes but equal responses to dominant epitopes and similar rates of survival following a tumour challenge. The impairment of cell–cell fusion and the enhanced immunogenicity profile of this HERV-W vaccine strengthens the prospects of obtaining a meaningful immune response against HERV-W in patients with HERV-W-overexpressing cancers.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Immunology and Microbiology, University of Copenhagen, Blegdamsvej 3B, 2200 Copenhagen, Denmark.
- InProTher, COBIS, Ole Maaloesvej 3, 2200 Copenhagen, Denmark.
- Institute of Medical Microbiology and Hygiene, Molecular Microbiology, University of Regensburg Germany, 93053 Regensburg, Germany.
- Department of Biomedical Sciences, University of Copenhagen, Blegdamsvej 3B, 2200 Copenhagen, Denmark.
- Sirion Biotech GmbH, Am Haag 6, 82166 Graefelfing, Germany.
ORCID-Profile: Emeline Ragonnaud, Silke Schrödel
Förderung
- Eurostars-2 programme
Zitieren
APA
Skandorff, I., Gille, J., Ragonnaud, E., Andersson, A. M., Schrödel, S., Thirion, C., Wagner, R., & Holst, P. J. (2023). The Insertion of an Evolutionary Lost Four-Amino-Acid Cytoplasmic Tail Peptide into a Syncytin-1 Vaccine Increases T- and B-Cell Responses in Mice. Viruses, 15(8), 1686. https://doi.org/10.3390/v15081686
Vancouver
Skandorff I, Gille J, Ragonnaud E, Andersson AM, Schrödel S, Thirion C, et al. The Insertion of an Evolutionary Lost Four-Amino-Acid Cytoplasmic Tail Peptide into a Syncytin-1 Vaccine Increases T- and B-Cell Responses in Mice. Viruses. 2023;15(8):1686. doi:10.3390/v15081686
BibTeX
@article{Skandorff2023,
author = {Skandorff, Isabella and Gille, Jasmin and Ragonnaud, Emeline and Andersson, Anne-Marie and Schrödel, Silke and Thirion, Christian and Wagner, Ralf and Holst, Peter Johannes},
title = {The Insertion of an Evolutionary Lost Four-Amino-Acid Cytoplasmic Tail Peptide into a Syncytin-1 Vaccine Increases T- and B-Cell Responses in Mice},
journal = {Viruses},
year = {2023},
volume = {15},
number = {8},
pages = {1686},
doi = {10.3390/v15081686}
}
EUVIMED